Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Menopausal Disorder Treatment Market Growth in 2025?

The market for treatment of menopausal disorders has seen robust growth in the recent past. It’s predicted to rise from a worth of $10.69 billion in 2024, to a projected value of $11.50 billion in 2025, representing a compound annual growth rate (CAGR) of 7.6%. Factors contributing to this growth during the historic time frame include an aging female demographic, rising consciousness around health problems associated with menopause, a high incidence of obesity intensifying menopausal symptoms, an increase in the uptake of hormone replacement therapy (HRT), and progress in precision medicine.

What Is the Forecast for the Menopausal Disorder Treatment Market Size Through 2029?

Expected robust growth in the menopausal disorder treatment market will likely see its valuation increasing to $15.30 billion by 2029, with a compound annual growth rate (CAGR) of 7.4%. This growth during the forecast period is primarily due to increased healthcare infrastructure spending, heightened attention to women’s health, increasing alliances between pharmaceutical firms and research bodies, and increased urbanization influencing lifestyle modifications that affect menopausal health. Key trends to watch in the forecast period include a propensity for natural and herbal treatment, the incorporation of artificial intelligence in treatment strategies, the rise of wearable tech for real-time symptom tracking, a focus on all-inclusive wellness programs tailored towards menopause, and increased funding in startups dealing with women’s health, specifically menopause treatments.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24318&type=smp

What are the Key Market Players in Menopausal Disorder Treatment Market and How They’re Evolving?

Major companies operating in the menopausal disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Sanofi SA, AstraZeneca plc, Eli Lilly and Company, Novo Nordisk A/S, Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Ipsen SA, Dr. Reddy’s Laboratories Ltd., Theramex, Besins Healthcare, Mithra Pharmaceuticals, Duchesnay USA, Fervent Pharmaceuticals, Joylux Inc., TherapeuticsMD Inc.

What Are the Primary Growth Drivers in the Menopausal Disorder Treatment Market?

The growth of the menopausal disorder treatment market is set to be fueled by the escalating demand for hormone replacement therapies (HRT). Essentially, HRT is a medical procedure that supplements or substitutes hormones to soothe symptoms related to menopause or hormone inconsistencies. The surge in HRTs is attributed to a growing awareness and the need for effective control of menopausal symptoms and hormone imbalances. HRT addresses menopausal disorder by directly supplementing estrogen and progesterone levels, which aids in rebalancing hormones and lessening troublesome symptoms, such as hot flashes, night sweats, and mood swings, markedly enhancing the quality of life. For example, in October 2024, a 22% rise in HRT prescribed items was reported by NHS Business Services Authority (NHSBSA), an organization based in the UK offering a variety of support services. This was a total of 13 million, accompanied by a 12% hike in identified patients from 2.3 million in 2022/23 to 2.6 million in 2023/24. Consequently, the escalating demand for HRT is stimulating the growth of the menopausal disorder treatment market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24318&type=smp

What Are the Leading Segments in the Global Menopausal Disorder Treatment Industry?

The menopausal disorder treatment market covered in this report is segmented –

1) By Treatment Type: Hormone Replacement Therapy, Non-Hormonal Treatment, Herbal Supplements, Lifestyle Modifications

2) By Stages: Menopause, Postmenopause, Perimenopause

3) By Application: Hot Flashes, Night Sweats, Mood Swings, Vaginal Dryness

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Hormone Replacement Therapy (HRT): Estrogen Therapy, Progesterone Therapy, Combination Therapy, Transdermal Patches, Vaginal Estrogen, Oral Tablets

2) By Non-Hormonal Treatment: Selective Estrogen Receptor Modulators (SERMs), Antidepressants, Gabapentin, Clonidine, Bisphosphonates, Calcium And Vitamin D Supplements

3) By Herbal Supplements: Black Cohosh, Red Clover, Dong Quai, Ginseng, Soy Isoflavones, Flaxseed

4) By Lifestyle Modifications: Dietary Changes, Regular Physical Exercise, Stress Management Techniques, Cognitive Behavioral Therapy (CBT), Smoking Cessation, Sleep Hygiene Practices

What Are the Key Market Trends in the Menopausal Disorder Treatment Industry?

Leading businesses in the menopausal disorder treatment market are pioneering nonhormonal neurokinin 3 (NK3) receptor antagonist drugs that can efficiently alleviate vasomotor symptoms without the use of hormone therapy. These novel treatments work by blocking NK3 receptors to handle menopausal symptoms without the use of hormones. For example, Astellas Pharma Inc., a pharmaceutical company based in Japan, got the European Commission’s approval in December 2023 for Veozah (fezolinetant), a non-hormonal NK3 receptor antagonist. This drug is used to treat moderate to severe vasomotor symptoms (VMS), such as hot flashes and night sweats in menopausal women. This antagonist functions by targeting neurons in the brain’s temperature control center, helping to diminish the frequency and severity of these symptoms.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/menopausal-disorder-treatment-global-market-report

What Is the Regional Outlook for the Menopausal Disorder Treatment Market?

North America was the largest region in the menopausal disorder treatment market in 2024. The regions covered in the menopausal disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/customise?id=24318&type=smp

This Report Delivers Insight On:

1. How big is the menopausal disorder treatment market, and how is it changing globally?

2. Who are the major companies in the menopausal disorder treatment market, and how are they performing?

3. What are the key opportunities and risks in the menopausal disorder treatment market right now?

4. Which products or customer segments are growing the most in the menopausal disorder treatment market?

5. What factors are helping or slowing down the growth of the menopausal disorder treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model